Skip to main content
. 2024 Jan 30;14(1):e075846. doi: 10.1136/bmjopen-2023-075846

Figure 1.

Figure 1

Summary of the study design and schedule. LHRH, luteinising hormone-releasing hormone; mpMRI, multiparametric MRI; PET, positron emission tomography; PSMA, prostate-specific membrane antigen; SBRT, stereotactic radiotherapy.